- Home
- VVX vs BEAM Comparison
VVX vs BEAM Comparison
Compare VVX & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VVX
- BEAM
- Stock Information
- Founded
- VVX 2014
- BEAM 2017
- Country
- VVX United States
- BEAM United States
- Employees
- VVX N/A
- BEAM N/A
- Industry
- VVX Diversified Commercial Services
- BEAM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VVX Consumer Discretionary
- BEAM Health Care
- Exchange
- VVX Nasdaq
- BEAM Nasdaq
- Market Cap
- VVX 1.7B
- BEAM 1.9B
- IPO Year
- VVX 2014
- BEAM 2020
- Fundamental
- Price
- VVX $51.45
- BEAM $25.75
- Analyst Decision
- VVX Buy
- BEAM Buy
- Analyst Count
- VVX 8
- BEAM 10
- Target Price
- VVX $66.50
- BEAM $48.75
- AVG Volume (30 Days)
- VVX 212.9K
- BEAM 1.1M
- Earning Date
- VVX 02-24-2025
- BEAM 02-25-2025
- Dividend Yield
- VVX N/A
- BEAM N/A
- EPS Growth
- VVX N/A
- BEAM N/A
- EPS
- VVX 0.28
- BEAM N/A
- Revenue
- VVX $4,204,710,000.00
- BEAM $349,643,000.00
- Revenue This Year
- VVX $8.60
- BEAM N/A
- Revenue Next Year
- VVX $4.95
- BEAM $14.08
- P/E Ratio
- VVX $182.24
- BEAM N/A
- Revenue Growth
- VVX 7.79
- BEAM 328.73
- 52 Week Low
- VVX $37.04
- BEAM $20.84
- 52 Week High
- VVX $69.75
- BEAM $49.50
- Technical
- Relative Strength Index (RSI)
- VVX 46.84
- BEAM 49.43
- Support Level
- VVX $51.30
- BEAM $24.33
- Resistance Level
- VVX $54.38
- BEAM $27.97
- Average True Range (ATR)
- VVX 1.70
- BEAM 1.55
- MACD
- VVX 0.26
- BEAM 0.13
- Stochastic Oscillator
- VVX 47.47
- BEAM 59.41
About VVX V2X Inc.
V2X Inc is a U.S.-based company that provides services to the U.S. government. It operates as one segment and offers facility and logistics services and information technology mission support and engineering and digital integration services. The information technology and network communications capabilities consist of communications systems operations and maintenance, management and service support, systems installation and activation, system-of-systems engineering and software development, and mission support for the department of defense. The facility and logistics service include airfield management, ammunition management, civil engineering, communications, emergency services, life support activities, public works, security, transportation operations, and others.
About BEAM Beam Therapeutics Inc.
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.